Sign Up to like & get
recommendations!
0
Published in 2025 at "Infectious diseases"
DOI: 10.1080/23744235.2025.2597465
Abstract: BACKGROUND The management of Acinetobacter baumannii infections has become increasingly challenging due to extensive antimicrobial resistance. OBJECTIVES This study evaluated the in vitro activity of cefiderocol and sulbactam-durlobactam and characterised OXA-type enzyme diversity in carbapenem-resistant A.…
read more here.
Keywords:
sulbactam durlobactam;
cefiderocol;
baumannii;
carbapenem resistant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae140
Abstract: Abstract Background In a previous study, the efficacy and safety of sulbactam-durlobactam vs colistin for the treatment of patients with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) infections were evaluated in a randomized controlled phase 3 trial.…
read more here.
Keywords:
monomicrobial polymicrobial;
sulbactam durlobactam;
durlobactam;
baumannii calcoaceticus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11121793
Abstract: Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in…
read more here.
Keywords:
sulbactam durlobactam;
systematic review;
acinetobacter baumannii;
resistance ... See more keywords